Boregowda K, Joels L, Stephens JW, Price DE (2011)

Persistent primary hypogonadism associated with anabolic

steroid abuse.

Fertil Steril

96:e7

–

e8.

Buckley WE, Yesalis CE 3rd, Friedl KE, Anderson WA, Streit

AL, Wright JE (1988) Estimated prevalence of anabolic

steroid use among male high school seniors.

JAMA

260:3441

–

3445.

Byrnes JP (2002) The development of decision-making.

J Adolesc Health

31:208

–

215.

Cohen J, Collins R, Darkes J, Gwartney D (2007) A league of

their own: demographics, motivations and patterns of use of

1,955 male adult non-medical anabolic steroid users in the

United States.

J Int Soc Sports Nutr

4:12.

Coward RM, Rajanahally S, Kovac JR, Smith RP, Pastuszak

AW, Lipshultz LI (2013) Anabolic steroid induced

hypogonadism in young men.

J Urol

190:2200

–

2205.

Dohle GR, Smit M, Weber RF (2003) Androgens and male

fertility.

World J Urol

21:341

–

345.

Evans NA (2004) Current concepts in anabolic-androgenic

steroids.

Am J Sports Med

32:534

–

542.

Gazvani MR, Buckett W, Luckas MJ, Aird IA, Hipkin LJ,

Lewis-Jones DI (1997) Conservative management of

azoospermia following steroid abuse.

Hum Reprod

12:1706

–

1708.

Gill GV (1998) Anabolic steroid induced hypogonadism

treated with human chorionic gonadotropin.

Postgrad Med J

74:45

–

46.

Hough DO (1990) Anabolic steroids and ergogenic aids.

Fam Physician

41:1157

–

1164.

Hsieh TC, Pastuszak AW, Hwang K, Lipshultz LI (2013)

Concomitant intramuscular human chorionic

gonadotropin preserves spermatogenesis in men

undergoing testosterone replacement therapy.

J Urol

189:647

–

650.

Igra V, Irwin C (1995) Theories of adolescent risk-taking

behavior. In: Handbook of Adolescent Health Risk Behavior.

DiClemente R, Hanson W, Ponton L (eds). Plenum, New

York, pp. 35

–

51.

Ioannidou-Kadis S, Wright PJ, Neely RD, Quinton R (2006)

Complete reversal of adult-onset isolated hypogonadotropic

hypogonadism with clomiphene citrate.

Fertil Steril

86:1513

e1515

–

1513 e1519.

Jarow JP, Lipshultz LI (1990) Anabolic steroid-induced

hypogonadotropic hypogonadism.

Am J Sports Med

18:429

–

431.

Kanayama G, Pope HG Jr, Hudson JI (2001) “Body image”

drugs: a growing psychosomatic problem.

Psychother

Psychosom

70:61

–

65.

Kicman AT (2008) Pharmacology of anabolic steroids.

Br J

Pharmacol

154:502

–

521.

Knuth UA, Maniera H, Nieschlag E (1989) Anabolic steroids

and semen parameters in bodybuilders.

Fertil Steril

52:1041

–

1047.

Landry GL, Primos WA Jr (1990) Anabolic steroid abuse.

Adv

Pediatr

37:185

–

205.

Lindstrom M, Nilsson AL, Katzman PL, Janzon L, Dymling

JF (1990) Use of anabolic-androgenic steroids among

body builders

–

frequency and attitudes.

J Intern Med

227:407

–

411.

Maravelias C, Dona A, Stefanidou M, Spiliopoulou C (2005)

Adverse effects of anabolic steroids in athletes. A constant

threat.

Toxicol Lett

158:167

–

175.

Martikainen H, Alen M, Rahkila P, Vihko R (1986) Testicular

responsiveness to human chorionic gonadotrophin during

transient hypogonadotrophic hypogonadism induced by

androgenic/anabolic steroids in power athletes.

J Steroid

Biochem

25:109

–

112.

Menon DK (2003) Successful treatment of anabolic steroid-

induced azoospermia with human chorionic gonadotropin

and human menopausal gonadotropin.

Fertil Steril

(Suppl. 3):1659

–

1661.

Moretti E, Collodel G, La Marca A, Piomboni P, Scapigliati G,

Baccetti B (2007) Structural sperm and aneuploidies studies

in a case of spermatogenesis recovery after the use of

androgenic anabolic steroids.

J Assist Reprod Genet

24:

195

–

198.

Nelson CJ, Deveci S, Stasi J, Scardino PT, Mulhall JP (2010)

Sexual bother following radical prostatectomyjsm.

J Sex Med

7:129

–

135.

Parkinson AB, Evans NA (2006) Anabolic androgenic

steroids: a survey of 500 users.

Med Sci Sports Exerc

38:644

–

651.

Pirola I, Cappelli C, Delbarba A, Scalvini T, Agosti B, Assanelli

D, Bonetti A, Castellano M (2010) Anabolic steroids

purchased on the internet as a cause of prolonged

hypogonadotropic hypogonadism.

Fertil Steril

94:2331

e2331

–

2331 e2333.

Rahnema CD, Lipshultz LI, Crosnoe LE, Kovac JR, Kim ED

(2014) Anabolic-steroid induced hypogonadism: diagnosis

and treatment.

Fertil Steril

101:1271

–

1279.

Rashid H, Ormerod S, Day E (2007) Anabolic androgenic

steroids: what the psychiatrist needs to know.

Adv Psychiatr

Treat

13:203

–

211.

Sanford K (2012) The communication of emotion during

con±ict in married couples.

J Fam Psychol

26:297

–

307.

Schurmeyer T, Knuth UA, Belkien L, Nieschlag E (1984)

Reversible azoospermia induced by the anabolic steroid

19-nortestosterone.

Lancet

1:417

–

420.

Shahidi NT (2001) A review of the chemistry, biological

action, and clinical applications of anabolic-androgenic

steroids.

Clin Ther

23:1355

–

1390.

Shokri S, Aitken RJ, Abdolvahhabi M, Abolhasani F, Ghasemi

FM, Kashani I, Ejtemaeimehr S, Ahmadian S, Minaei B,

Naraghi MA, Barbarestani M (2010) Exercise and

supraphysiological dose of nandrolone decanoate increase

apoptosis in spermatogenic cells.

Basic Clin Pharmacol

Toxicol

106:324

–

330.

Silvester LJ (1995) Self-perceptions of the acute and long-

range effects of anabolic-androgenic steroids.

J Strength

Cond Res

9:95

–

98.

2014 Blackwell Verlag GmbH

877

Andrologia

2015,

, 872–878

J. R. Kovac

et al.

Anabolic steroid use and regret